 |
|
Aggressive Plasma Cell MyelomaA Terminal Phase
Anthony L. Suchman, MD;
Morton Coleman, MD;
Janet A. Mouradian, MD;
David J. Wolf, MD;
Stephen Saletan, MD
Arch Intern Med. 1981;141(10):1315-1320.
Abstract
• Seven patients with plasma cell myeloma experienced an aggressive, terminal phase. This phase is characterized by rapidly enlarging soft-tissue masses with tumor morphologic characteristics similar to a poorly differentiated or large-cell (histiocytic) lymphoma, with rapid death, and often with fever, pancytopenia, decreasing levels of myeloma protein, and younger age. Median survival from the onset of the phase was four months. There was no response to single-agent or combination chemotherapy. In view of the extremely poor prognosis and lack of response to conventional treatment, patients experiencing this characteristic terminal phase should be considered candidates for innovative therapy.
(Arch Intern Med 1981;141:1315-1320)
Author Affiliations
From the Oncology Service, Division of Hematology-Oncology, Department of Medicine (Drs Wolf, Coleman, Suchman, and Saletan), and the Department of Pathology (Dr Mouradian), Cornell University Medical College, New York.
Footnotes
Accepted for publication Aug 25, 1980.
Reprint requests to the Division of Hematology-Oncology, Department of Medicine, the New York Hospital-Cornell Medical Center, 525 E 68th St, New York, NY 10021 (Dr Coleman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Kyle et al.
Mayo Clin Proc. 2003;78:21-33.
ABSTRACT
Multiple Myeloma: An Overview in 1996
Kyle
The Oncologist 1996;1:315-323.
ABSTRACT
| FULL TEXT
Aggressive Phase of Multiple Myeloma With Pulmonary Plasma Cell Infiltrates
Garewal and Durie
JAMA 1982;248:1875-1876.
ABSTRACT
|
